We observed that Gal-1 is basally expressed in parental drug-sensitive melanoma cells, but its silencing had no significant impact on their viability in the absence of BRAF inhibitors (Figure 2A), suggesting that in this condition Gal-1 autocrine signaling is either disabled or irrelevant for growth. This evidence concerns the gene LGALS1 and melanoma.